Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,030 public trials 1,171 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

National Liver Cancer Screening Trial

NCT06084234

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +22 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Stanford University Redwood City, California, United States
  • Kaiser Permanente Roseville, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 18 locations
View Trial Details
Recruiting

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

NCT07239245

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
  • Shanxi Cancer Hospital Taiyuan, Shanxi, China
View Trial Details
Recruiting

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

NCT02620852

Conditions
Adenocarcinoma, Breast Cancer, Breast Cancer Screening, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California Irvine Irvine, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
View all 16 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

NCT05770037

Conditions
Adenocarcinoma, Anaplastic Large Cell Lymphoma, Cancer, +37 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details

Related conditions